Lymphangioma circumscriptum of buttock mimicking lupus vulgaris and responding with anti-tubercular chemotherapy
DOI:
https://doi.org/10.66344/jpad.23.1.2013.269Keywords:
Lymphangioma circumscriptum, anti-tubercular chemotherapyAbstract
Lymphangioma circumscriptum (LC) is a form of lymphangioma involving skin and subcutaneous tissue. Circumscriptum as its name suggests, is a well-circumscribed small lesion but it has a rare extensive variety also. LC may resemble other entities such as metastatic carcinoma of skin, lymphangiectasis, syringocystadenoma papilliferum, lupus vulgaris, actinomycosis etc. It is a difficult condition to treat. Different modalities of treatment such as surgical excision, laser, sclerotherapy, radiofrequency coagulation are used to treat this condition. We report here clinical presentation mimicking lupus vulgaris and responding with anti-tubercular (ATT) chemotherapy.ÂReferences
Mulliken JB, Young A, eds. Vascular Birthmarks, Hemangiomas and Vascular Malformations. Philadelphia: WB Saunders; 1988.
Kura MK, Rane VK. Cervicofacial actinomycosis mimicking lymphangioma circumscriptum – a case report. Indian J Dermatol. 2011;56:321-3.
Abu-Hamad A, Provencher D, Ganjee P, Penaher M. Lymphangioma circumscriptum of vulva; a case report and review of literature. Obstet Gynecol. 1989;73:262-3.
Peachey RD, Lim CC, Whimster IW. Lymphangioma of skin. A review of 65 cases. Br J Dermatol. 1970;83:519-27.
Whimster IW. The pathology of lymphangioma circumscriptum. Br J Dermatol. 1976;94:473-86.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.